New combination of drugs to reduce postoperative pain associated with paediatric inguinal hernia repair

Efficacy Of Hetastarch With Ropivacaine In Prolongation Of Duration Of Ilioinguinal And Iliohypogatsric Nerve Blocks In Paediatric Inguinal Hernia Repair

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017620

Enrollment

Registered

2019-02-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K409- Unilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention1: Hetastarch is mixed with ropivacaine: diluting 0.5% of ropivacaine with hetastarch to 0.25% and giving ilioinguinal and iliogypogastric nerve blocks and looking for duration of iliohypo

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA I and I 2. Pediatric patients of inguinal hernias aged between 1-7 years 3.All those parents or legal guardian giving consent

Exclusion criteria

Exclusion criteria: 1. patient or guardian refusal 2. Patient with coagulopathy (INR >1.5,platelet count 3. Patient with infection at puncture site. 4. Patient with allergy to local anaesthetic and hetastarch . 5.preexisting neurological disease.

Design outcomes

Primary

Measure	Time frame
To study for the time for the first requirement of analgesic postoperativelyTimepoint: Monitored for 6 hours	—

Secondary

Measure	Time frame
1.To study the local side effects associated with hetastarch when used in nerve blocks 2.intraoperative analgesic requirement 3.postopeartive analgesic requirementTimepoint: Monitored for 6 hours postoperatively	—

Countries

India

Contacts

Public ContactSachin Kumar

AIIMS ,NEW DELHI

drgpd@yahoo.com9013232965

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026